Literature DB >> 2578914

Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate.

K C Flint, K B Leung, F L Pearce, B N Hudspith, J Brostoff, N M Johnson.   

Abstract

Mast cells make up between 0.5 and 3% (mean 1.35%) of total cells recovered by bronchoalveolar lavage (BAL). The majority of these cells have the morphological characteristics of mucosal mast cells in that they fail to stain in the alcian blue-safranin reaction after fixation in formol-saline but stain well after fixation in Carnoy's solution. Cells staining with berberine sulphate were seen in only four of the 26 lavages. BAL cells released histamine in response to anti-human immunoglobulin E (IgE) in a dose-dependent manner that was optimal at a dilution of anti-IgE of 1:100. Maximum release was obtained by 2 min. Histamine release was completely inhibited by a combination of 2-deoxyglucose (5 mmol/l) and antimycin A (1 mumol/l). Disodium cromoglycate (DSCG) significantly inhibited this histamine release at 1 mmol/l (P less than 0.02), 100 mumol/l (P less than 0.002) and 10 mumol/l (P less than 0.003), with maximum inhibition of 50.1% at 10 mumol/l.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578914     DOI: 10.1042/cs0680427

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  26 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; N M Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

3.  Lamina propria mast cells in biopsies from children with Crohn's disease.

Authors:  I R Sanderson; K B Leung; F L Pearce; J A Walker-Smith
Journal:  J Clin Pathol       Date:  1986-03       Impact factor: 3.411

4.  Bronchoalveolar mast cells in sarcoidosis: increased numbers and accentuation of mediator release.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; D Geraint-James; N M Johnson
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

5.  Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?

Authors:  M K Church
Journal:  Agents Actions       Date:  1986-06

6.  Evaluation of an in vitro degranulation challenge procedure for equine pulmonary mast cells.

Authors:  J E Hare; L Viel; P D Conlon; J S Marshall
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

Review 7.  Staub and Bovet Award 1989 lecture. Some aspects of mast cell subtypes from human lung tissue.

Authors:  F J van Overveld
Journal:  Agents Actions       Date:  1990-04

8.  Changes in mast cell reactivity in the course of allergic inflammation.

Authors:  F L Pearce; A M Frenz; P M Shah
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

9.  Some properties of mast cells obtained by human bronchoalveolar lavage.

Authors:  K B Leung; K C Flint; J Brostoff; B N Hudspith; N M Johnson; F L Pearce
Journal:  Agents Actions       Date:  1986-04

10.  Mast cell subtypes from human lung tissue: their identification, separation, and functional characteristics.

Authors:  F J van Oveveld; L A Houben; P L Bruijnzeel; J A Raaijmakers; G K Terpstra; J Kreukniet
Journal:  Agents Actions       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.